Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Wen, Patrick Y, Weller, Michael, Lee, Eudocia Quant, Alexander, Brian M, Barnholtz-Sloan, Jill S, Barthel, Floris P, Batchelor, Tracy T, Bindra, Ranjit S +32 more·2020·Neuro-Oncology

DOI 10.1093/neuonc/noaa106

Cited by (1,000)

Items 201–300 of 1,000

Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma
Jawad Fares, Yizhou Wan, Richard James Mair, Stephen John Price · 2024 · Brain Communications
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Rifaquat M. Rahman, Diana D. Shi, Zachary J. Reitman, Petra Hamerlik, John de Groot, Daphne Adele Haas-Kogan, Alan D. D’Andrea, Erik P. Sulman, Kirk G. Tanner, Nathalie Y.R. Agar et al. · 2024 · Neuro-Oncology
Targeted Radionuclide Therapy in Glioblastoma
Xiaobin Zhao, Vivianne Jakobsson, Yucen Tao, Tianzhi Zhao, Jingyan Wang, Pek‐Lan Khong, Xiaoyuan Shawn Chen, Jingjing Zhang · 2024 · ACS Applied Materials & Interfaces
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements
Javier E. Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, Janine Lupo, Evan Calabrese, Christos A. Davatzikos, Wenya Linda Bi, Marwa Ismail, Hamed Akbari, Philipp Lohmann et al. · 2024 · The Lancet Oncology
Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas
Shaozhen Xie, Jing Ni, Jose Ricardo McFaline-Figueroa, Yanzhi Wang, Roderick Terry Bronson, Keith Lloyd Ligon, Patrick Yung Wen, Thomas M. Roberts, Jean J. Zhao · 2020 · Cell Reports
Glioblastoma: Emerging Treatments and Novel Trial Designs
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes · 2021 · Cancers
Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma
Jingjing Wei, Yifeng Xia, Fenghua Meng, Dawei Ni, Xinyun Qiu, Zhiyuan Zhong · 2021 · Biomacromolecules
Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
Kacper Adam Walentynowicz, Dalit Engelhardt, Simona Cristea, Shreya Yadav, Ugoma Onubogu, Roberto Salatino, Melanie Maerken, Cristina Vincentelli, Aashna Jhaveri, Jacob Geisberg et al. · 2023 · Cell Reports
Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model
Francesco Paolo Cammarata, Filippo Torrisi, Nunzio Vicario, Valentina Bravatà, Alessandro Stefano, Lucia Salvatorelli, Simona D’Aprile, Pierangela Giustetto, Giusi Irma Forte, Luigi Minafra et al. · 2023 · Communications Biology
Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study
Line Sagerup Bjorland, Rupavathana Mahesparan, Øystein Fluge, Bjørnar Gilje, Kathinka Daehli Kurz, Elisabeth Farbu · 2023 · Neuro-Oncology Advances
EGFR alterations in glioblastoma play a role in antitumor immunity regulation
Xiao-Peng Li, Zheng‐Qian Guo, Baofeng Wang, Min Zhao · 2023 · Frontiers in Oncology
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
Jie Liu, Xinyu Gu, Zhenjie Guan, Di Huang, Huiwu Xing, Zheng Lian · 2023 · Journal of Translational Medicine
Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems
Martina Schuster, Frank Braun, Dapi Menglin Chiang, Christina Ludwig, Chen Meng, Christian Grätz, Benedikt Kirchner, Martin Andreas Proescholdt, Peter Hau, Ortrud K. Steinlein et al. · 2024 · Frontiers in Immunology
Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis
Lucas Cunha Barbosa, Gabriel Cardoso Machado, Manoela Heringer, Valéria Pereira Ferrer · 2024 · Neurogenetics
Liquid biopsies for the monitoring of gliomas and brain metastases in adults
Govert Dwarshuis, Lente L. Kroon, Dieta Brandsma, David P. Noske, Myron G. Best, Nik Sol · 2025 · Acta Neuropathologica
An update on the clinical trial research of immunotherapy for glioblastoma
Yichen Zhou, Fanxing Shi, Junyu Zhu, Yi Yuan · 2025 · Frontiers in Immunology
The Role of NKT Cells in Glioblastoma
Emily E. S. Brettschneider, Masaki Terabe · 2021 · Cells
Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma—a systematic review
Kavi Fatania, Farah Mohamud, Anna Clark, Michael G. Nix, Susan C Short, James P.B. O’Connor, Andrew Frederick Scarsbrook, Stuart Currie · 2022 · European Radiology
Integrative multi-omics approach to targeted therapy for glioblastoma
Lynnette Koh, Wisna Novera, See Wee Lim, Yuk Kien Chong, Qing You Pang, David C.Y. Low, Beng Ti Ang, Carol Tang · 2022 · Pharmacological Research
[68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
Peter Truckenmueller, Josefine Graef, Michael Scheel, Peter Vajkoczy, David Capper, David Kaul, Christian Furth, Holger Amthauer, Winfried Brenner, Julia Onken · 2022 · Frontiers in Oncology
Performance of 18 F-FAPI PET/CT in assessing glioblastoma before radiotherapy: a pilot study
Yutang Yao, Xiaofei Tan, Wenya Yin, Ying Kou, Xiaoxiong Wang, Xiao Jiang, Shirong Chen, Yongli Liu, Jun Dang, Jun Yin et al. · 2022 · BMC Medical Imaging
Artificial intelligence in neuro-oncology
Vihang Nakhate, L. Nicolas Gonzalez Castro · 2023 · Frontiers in Neuroscience
SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines
Filippo Torrisi, Luigi Minafra, Francesco Paolo Cammarata, Gaetano Savoca, Marco Calvaruso, Nunzio Vicario, Laura Maccari, Elodie Anne Pérès, Hayriye Özçelik, Myriam Bernaudin et al. · 2020 · International Journal of Molecular Sciences
Negative trials over and over again: how can we do better?
McFaline-Figueroa, J Ricardo, Wen, Patrick Y · 2023 · Neuro-Oncology
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older
Christina Stadler, Dorothee Gramatzki, Émilie Le Rhun, Andreas Felix Hottinger, Thomas Hundsberger, Ulrich Roelcke, Heinz Philipp Laubli, Silvia Höfer, Katharina Seystahl, Hans‐Georg Wirsching et al. · 2023 · Neuro-Oncology Practice
Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma
Allison R. Valerius, Lauren M. Webb, Anna Thomsen, Eric J. Lehrer, William G. Breen, Jian Li Campian, Cécile Riviere-Cazaux, Terry C. Burns, Ugur T. Sener · 2024 · International Journal of Molecular Sciences
Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients
Syed Mohd Faisal, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2023 · Molecular Therapy
Risk factors for glioblastoma are shared by other brain tumor types
Carr J. Smith, Thomas A. Perfetti, Chirayu Chokshi, Chitra Venugopal, John Wesson Ashford, Sheila Kumari Singh · 2024 · Human & Experimental Toxicology
Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
Yuxiang Fan, Xinyu Peng, Yubo Wang, Baoqin Li, Gang Zhao · 2021 · Frontiers in Molecular Biosciences
Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK
Fangzhou Guo, Guoyuan Ling, Jianting Qiu, Ji‐Cheng Li, Yu Gan, Yingying Yu, Jiamei Tang, Ligen Mo, Haozhe Piao · 2024 · Chinese Medicine
Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas
Giuseppe Caracciolo Minniti, Sergio Paolini, M. Rea, Andrea Maria Isidori, Claudia Scaringi, Ivana Russo, Mattia Falchetto Osti, Luigi Maria Cavallo, Vincenzo Esposito · 2020 · Journal of Neuro-Oncology
Re-irradiation for high-grade gliomas: Has anything changed?
Sonia García Cabezas, Eleonor Rivin del Campo, J. Solivera Vela, Amalia Palacios · 2021 · World Journal of Clinical Oncology
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
Maximilian A. Kirchner, Adrien Holzgreve, Matthias Brendel, Michael Orth, Viktoria Ruf, Katja Steiger, Dennis Pötter, Lukas Gold, Marcus Unterrainer, Lena M. Mittlmeier et al. · 2021 · Frontiers in Oncology
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori · 2023 · Japanese Journal of Clinical Oncology
A critical analysis of neuro-oncology clinical trials
Yeonju Kim, Terri S. Armstrong, Mark R. Gilbert, Orieta Celiku · 2023 · Neuro-Oncology
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine A. Dominas, Geoffrey G. Fell, Joshua D. Bernstock, Sarah E. Blitz, Debora Mazzetti, Mykola I. Zdioruk, Hassan Y. Dawood, Daniel Triggs, Sebastian W. Ahn et al. · 2023 · Science Translational Medicine
Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically-incurable disease
Yutaro Kubota, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Kazuyuki Hamada, Qinghong Han, Michael Bouvet, Takuya Tsunoda, Robert M. Hoffman · 2023 · Biochemical and Biophysical Research Communications
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA, Ryosuke Mori, Byung Mo Kang, Sei Morinaga, Noritoshi Kobayashi, YASUSHI ICHIKAWA, Atsushi Nakajima, Robert M. Hoffman · 2024 · In Vivo
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group
Philipp Karschnia, Jacob S. Young, Gilbert Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino, Francesco Bruno, Stephanie T Juenger, Nico Teske, Jörg Dietrich et al. · 2024 · Neuro-Oncology
Spherical Nucleic Acids as Precision Therapeutics for the Treatment of Cancer—From Bench to Bedside
Akanksha Sanjay Mahajan, Alexander H. Stegh · 2022 · Cancers
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Virginia Aragon‐Sanabria, Anusha Aditya, Li Zhang, Feng Chen, Barney Yoo, Tianye Cao, Brian Madajewski, Rachel Lee, Melik Ziya Turker, Kai Ma et al. · 2022 · Clinical Cancer Research
Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation
Hyungsin Kim, Jeongsoo Kim, Jason K. Sa, Byung–Kyu Ryu, Kyung-Jae Park, Jiyoung Kim, Hyojeong Ha, Yejin Park, Min Hwa Shin, Jungwon Kim et al. · 2022 · Biomedicine & Pharmacotherapy
CircSMARCA5: A key circular RNA in various human diseases
Yi Zhu, Gaozhen Huang, Shi-Hao Li, Hong Xiong, Ruiqi Chen, Ling Zuo, Hongwei Liu · 2022 · Frontiers in Genetics
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, Jakob Rüttinger, Maximilian Ehrenfeld, Eva Lichtenegger, Marcel A. Krüger, Klaus Mantwill, Florestan Johannes Koll, Markus Christian Kowarik et al. · 2022 · International Journal of Molecular Sciences
Role of extracellular vesicles in cancer-specific interactions between tumour cells and the vasculature.
L. Adnani, C. Spinelli, Nadim Tawil, J. Rak · 2022 · Seminars in Cancer Biology
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come Along
Alyx B. Porter, Patrick Yung Wen, Mei‐Yin C. Polley · 2023 · American Society of Clinical Oncology Educational Book
Ion Channels and Ionotropic Receptors in Astrocytes: Physiological Functions and Alterations in Alzheimer’s Disease and Glioblastoma
Annamaria Lia, Alessandro Di Spiezio, Lorenzo Vitalini, Manuela Tore, Giulia Puja, Gabriele Losi · 2023 · Life
Proteasome Inhibitors against Glioblastoma—Overview of Molecular Mechanisms of Cytotoxicity, Progress in Clinical Trials, and Perspective for Use in Personalized Medicine
Agata Góźdź · 2023 · Current Oncology
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Asmae Squalli Houssaini, Salma Lamrabet, Jean Paul Nshizirungu, Nadia Senhaji, Mohammed Sekal, Mehdi Karkouri, Sanae Bennis · 2024 · Vaccines
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Daniel Dubinski, Sae‐Yeon Won, Martin Voß, Fee Christiane Keil, Wolfgang Miesbach, Bedjan Behmanesh, M. Dosch, Peter Baumgarten, Joshua D. Bernstock, Volker Seifert et al. · 2021 · Neurosurgical Review
Efficacy and safety of intraoperative MRI in glioma surgery: a systematic review and meta-analysis of prospective randomized controlled trials
Johannes Wach, Martin Vychopen, Alim Emre Basaran, Ági Güresir, Clemens Seidel, Andreas Kühnapfel, Erdem Güresir · 2024 · Journal of neurosurgery
Patient specific, imaging-informed modeling of rhenium-186 nanoliposome delivery via convection-enhanced delivery in glioblastoma multiforme
Ryan T. Woodall, David A. Hormuth, Chengyue Wu, Michael Abdelmalik, William Thomas Phillips, Ande Bao, Thomas J.R. Hughes, Andrew Jacob Brenner, Thomas E Yankeelov · 2021 · Biomedical Physics & Engineering Express
Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors
Bernarda Majc, Anamarija Habič, Metka Novak, Ana Rotter, Andrej Porčnik, Jernej Mlakar, Vera Župunski, Urša Pečar Fonović, Damijan Knez, Nace Zidar et al. · 2022 · International Journal of Molecular Sciences
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors
Benjamin M. Ellingson, Elizabeth Robins Gerstner, Andrew B. Lassman, Caroline D. Chung, Howard Colman, Patricia E. Cole, David Ka-Wai Leung, Joshua E. Allen, Manmeet Singh Ahluwalia, Jerrold L. Boxerman et al. · 2022 · Neuro-Oncology
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
David König, Jürgen Hench, Stephan Frank, Laura Dima, Ivana Bratić Hench, Heinz Philipp Laubli · 2022 · Pharmacology
Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma
Yingying Zeng, Peixin Tan, Chen Ren, Lianxuan Gao, Yulei Chen, Shushu Hu, Nan Tang, Chen Chen, Shasha Du · 2022 · Frontiers in Genetics
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy
Francesco Pasqualetti, Celeste Giampietro, Nicola Montemurro, Noemi Giannini, Giovanni Gadducci, Paola Orlandi, Eleonora Natali, Paolo Chiarugi, Alessandra Gonnelli, MARTINA CANTARELLA et al. · 2022 · Genes
Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling
Binghong Chen, Mengying Wang, Junjun Qiu, Keman Liao, Wenrui Zhang, Qi Lv, Chunhui Ma, Zhongrun Qian, Zhonggang Shi, Rong Liang et al. · 2022 · Journal of Experimental & Clinical Cancer Research
Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies
Makoto Ohno, Chifumi Kitanaka, Yasuji Miyakita, Shota Tanaka, Yukihiko Sonoda, Kazuhiko Mishima, Eiichi Ishikawa, Masamichi Takahashi, Shunsuke Yanagisawa, Ken Ohashi et al. · 2022 · Cancers
Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance
Qiwei He, Junxiong Chen, Zijing Xie, Zhenzhou Chen · 2022 · Cancers
Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET
Jacquelyn T. Saunders, Sunil Kumar, Angelica Benavides-Serrato, Brent Holmes, Kennedy E. Benavides, Muhammad Tariq Bashir, Robert N. Nishimura, Joseph Gera · 2023 · Journal of Neuro-Oncology
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms
Jérémy Ariey-Bonnet, Raphaël Bergès, Marie-Pierre Montero, Baptiste Mouysset, Patricia Piris, Kévin Müller, Guillaume Pinna, Timothy W. Failes, Greg M. Arndt, Philippe Morando et al. · 2023 · EBioMedicine
Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies
K. Shimizu, Andranik Kahramanian, Muzammil Arif Din Abdul Jabbar, Fatma Turna Demir, Dilan Gokyer, Abicumaran Uthamacumaran, Anant P. Rajan, Mohammad Ahsan Saad, Joshua Gorham, Hiroko Wakimoto et al. · 2023 · Cancer Letters
Neuroinflammation in Glioblastoma: Progress and Perspectives
Xin Li, Wenting Gou, Xiaoqin Zhang · 2024 · Brain Sciences
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments
Katharina Johanna Müller, Robert Forbrig, Jonas Reis, Lilian Wiegand, Enio Barci, Sophie Carina Kunte, Lena Kaiser, Stephan Schönecker, Christian Schichor, Patrick N. Harter et al. · 2024 · Neuro-Oncology
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database
John D. Pham, David J. Coté, Keiko M. Kang, Robert Grady Briggs, David Gómez, Apurva Prasad, Sindhu Daggupati, Jonathan Sisti, Frances Elaine Chow, Frank Joseph Attenello et al. · 2025 · Journal of Neuro-Oncology
Spatial biology – unravelling complexity within the glioblastoma microenvironment
Stephen D. Robinson, Chrysa Filippopoulou, Simoni Besta, Mark E. Samuels, Andrea Lauer Betrán, Maha Abu Ajamieh, Viviana Vella, William Jones, Georgios Giamas · 2025 · Trends in Molecular Medicine
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Kenchappa, Rajappa S., Radnai, Laszlo, Young, Erica J., Zarco, Natanael, Lin, Li, Dovas, Athanassios, Meyer, Christian T., Haddock, Ashley, Hall, Alice, Toth, Katalin et al. · 2025 · Cell
Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma
Antonio Dono, Mark J. Amsbaugh, Magda Martir, Richard H. Smilie, Roy Riascos, Jay‐Jiguang Zhu, Sigmund H. Hsu, Dong Kim, Nitin Tandon, Leomar Y. Ballester et al. · 2021 · Journal of Neuro-Oncology
Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival
Felix Behling, J. Rang, Elena Dangel, Susan Noell, Mirjam Renovanz, Irina Mäurer, Jens Schittenhelm, Benjamin Bender, Frank Paulsen, Bettina Brendel et al. · 2022 · Frontiers in Oncology
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study
Mario Caccese, Matteo Simonelli, Veronica Villani, Simona Rizzato, Tamara Ius, Francesco Pasqualetti, Marco Russo, Roberta Rudà, Rosina Amoroso, Luisa Bellu et al. · 2022 · Cancers
Tumor Treating Fields (TTFields) therapy vs physicians’ choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)
Jay‐Jiguang Zhu, Samuel Aaron Goldlust, Lawrence Richard Kleinberg, Jérôme Honnorat, Nancy Ann Oberheim Bush, Zvi Ram · 2022 · Discover Oncology
3D‐conformal very‐high energy electron therapy as candidate modality for FLASH‐RT: A treatment planning study for glioblastoma and lung cancer
Till Tobias Böhlen, Jean‐François Germond, Erik Tranéus, Veronique Vallet, L. Desorgher, Mahmut Özşahin, François O. Bochud, Jean Bourhis, Raphaël Moeckli · 2023 · Medical Physics
Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
Marcin Niedbała, Katarzyna Malarz, Gitanjali Sharma, Gabriela Krämer-Marek, Wojciech Kaspera · 2022 · OncoTargets and Therapy
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity
Maikel Verduin, Linde Hoosemans, Maxime Vanmechelen, Mike van Heumen, Jolanda A. F. Piepers, Galuh Astuti, Linda P.C.M. Ackermans, Olaf E. M. G. Schijns, Kim Rosalie Kampen, Vivianne C. G. Tjan‐Heijnen et al. · 2023 · Neuro-Oncology Advances
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study
Ilanah J. Pruis, Pieter‐Jan van Doormaal, Rutger K. Balvers, Martin J. van den Bent, Anita A. Harteveld, Linda C. de Jong, Mark Konijnenberg, Marcel Segbers, Roelf Valkema, Frederik A. Verburg et al. · 2024 · EBioMedicine
Targeting legumain-mediated cell-cell interaction sensitizes glioblastoma to immunotherapy in preclinical models
Lizhi Pang, Songlin Guo, Yu-Yun Huang, Fatima Khan, Yang Liu, Zhou Fei, Justin Durla Lathia, Peiwen Chen · 2025 · Journal of Clinical Investigation
The expression and prognostic value of the epidermal growth factor receptor family in glioma
Bin Xu, Zhengyuan Huo, Hui Huang, Wei Ji, Zheng Bian, Jiantong Jiao, Jun Sun, Junfei Shao · 2021 · BMC Cancer
Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma
Ingo K. Mellinghoff, Timothy Francis Cloughesy · 2022 · Journal of Clinical Oncology
EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling
Dorothee Hölzl, Georg Hutarew, Barbara Zellinger, Beate Alinger-Scharinger, Hans U. Schlicker, Christoph Schwartz, Karl Sotlar, Theo F. J. Kraus · 2022 · Biomedicines
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model
Peng Zhao, Yasuaki Anami, Peng Gao, Xuejun Fan, Leike Li, Kyoji Tsuchikama, Ningyan Zhang, Zhiqiang An · 2022 · mAbs
Antibody-drug conjugates: beyond current approvals and potential future strategies
Siddharth Menon, Sagun Parakh, Andrew Mark Scott, Hui Kong Gan · 2022 · Exploration of Targeted Anti-tumor Therapy
Navigated Intraoperative 3D Ultrasound in Glioblastoma Surgery: Analysis of Imaging Features and Impact on Extent of Resection
Benjamin Saß, Darko Zivkovic, Mirza Pojskić, Christopher Nimsky, Miriam H. A. Bopp · 2022 · Frontiers in Neuroscience
The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
Aleksandrs Krigers, Daniel Pinggera, Matthias Demetz, Lisa-Marie Kornberger, Johannes Kerschbaumer, Claudius Thomé, Christian Franz Freyschlag · 2022 · Frontiers in Neurology
Biomimetic Hydrogels in the Study of Cancer Mechanobiology: Overview, Biomedical Applications, and Future Perspectives
Ayse Z. Sahan, Murat Baday, Chirag B. Patel · 2022 · Gels
Bioactive peptides from venoms against glioma progression
Bernarda Majc, Metka Novak, Tamara T. Lah, Igor Križaj · 2022 · Frontiers in Oncology
Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period
Peter Y. M. Woo, Stephen Yau, Tai‐Chung Lam, Jenny Kan-Suen Pu, Lai‐Fung Li, Louisa C Y Lui, Danny Tat Ming Chan, Herbert Ho-Fung Loong, Michael W. Y. Lee, Rebecca M.W. Yeung et al. · 2022 · Neuro-Oncology Practice
Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma
Zhen Ouyang, Hanyi Zhang, Wenrui Lin, Juan Su, Xianggui Wang · 2022 · Frontiers in Cell and Developmental Biology
New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction
Hongbo Bao, Peng Ren, Liye Yi, Zhonghua Lv, Wencai Ding, Chenlong Li, Siyang Li, Zhipeng Li, Yang Xue, Xia Liang et al. · 2022 · International Journal of Cancer
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik et al. · 2023 · Cancers
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
Maxim K. Sidorov, Pratiksha A. Dighe, Rinette W.L. Woo, Aida Rodriguez-Brotons, Michelle M. Chen, Ryan J. Ice, Edith M. Vaquero, Damon Jian, Pierre‐Yves Desprez, Mehdi Nosrati et al. · 2023 · Cells
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
Manuela Stella, Giammarco Baiardi, Stefano Pasquariello, Fabio Sacco, Irene Dellacasagrande, Alessandro Corsaro, Francesca Mattioli, Federica Barbieri · 2023 · Biomedicines
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
Fabrizio Celesti, Andrea Gatta, Mariam Shallak, Anna Maria Chiaravalli, Michele Cerati, Fausto Sessa, Roberto Sergio Accolla, Greta Forlani · 2023 · Frontiers in Immunology
EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma
Biao Hong, Eryan Yang, Dongyuan Su, Jiasheng Ju, Xiaoteng Cui, Qixue Wang, Fei Tong, Jixing Zhao, Shixue Yang, Chunchao Cheng et al. · 2023 · Neuro-Oncology
Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression
Juan Carlos Quintero, Néstor Fabián Díaz, Mauricio Rodríguez‐Dorantes, Ignacio Camacho‐Arroyo · 2023 · International Journal of Molecular Sciences
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas
Gilbert Youssef, Patrick Yung Wen · 2024 · Current Neurology and Neuroscience Reports
Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?
Thibault Lootens, Bart I. Roman, Christian Victor Stevens, Olivier De Wever, Robrecht Raedt · 2024 · International Journal of Molecular Sciences
Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report
Matthew C. L. Phillips, Ziad Thotathil, Prashanth Hari Dass, Fouzia Ziad, Ben G. Moon · 2024 · Oncology Letters
Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma
Bernarda Majc, Anamarija Habič, Marta Malavolta, Miloš Vittori, Andrej Porčnik, Róman Boŝnjak, Jernej Mlakar, Alenka Matjašič, Andrej Zupan, Marija Skoblar Vidmar et al. · 2024 · iScience
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
Sujay A. Vora, Deanna Pafundi, Molly M. Voss, Matthew R Buras, Jonathan B. Ashman, Bernard R. Bendok, William G. Breen, Leland Hu, Sani Haider Kizilbash, Nadia N. Laack et al. · 2024 · The Lancet Oncology